+454.2%
MRNA vs LDOS
-27.4%
+481.5%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | LDOS | Excess | Alpha |
|---|---|---|---|---|
| 1D | -3.4% | -0.9% | -2.5% | -2.8% |
| 7D | -10.1% | -4.2% | -5.9% | -7.6% |
| 30D | +126.7% | -7.9% | +134.6% | +144.0% |
| 3M | +184.1% | +4.1% | +180.0% | +192.8% |
| 6M | +143.3% | -28.2% | +171.5% | +194.8% |
| YTD | +359.9% | -28.5% | +388.4% | +446.5% |
| 1Y | +454.2% | -27.7% | +481.9% | +503.8% |
| All | +454.2% | -27.4% | +481.5% | +503.8% |
Cumulative growth
Daily Returns
Daily percentage return beside LDOS.
Daily Out/Under-Performance
Portfolio return minus LDOS return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × LDOS return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded LDOS wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling